Intervening to Prevent Youth Access to Marijuana Phase II
Public ClinicalTrials.gov record NCT03073291. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The legalization of recreational marijuana use and sales in Alaska, Colorado, Oregon, and Washington State is a dramatic change in U.S. substance abuse policy that places a priority on developing regulatory and enforcement systems that prevent distribution of retail recreational marijuana to minors. Responsible marijuana vendor training, modeled after effective responsible alcoholic beverage training, has the potential to help the states prevent distribution to minors. This research will produce a responsible marijuana vendor training provided by a third party, not the cannabis industry, and test its effectiveness with retail recreational marijuana licensees and employees in Colorado, Oregon, and Washington State.
Study identification
- NCT ID
- NCT03073291
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 448 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2016
- Primary completion
- May 30, 2019
- Completion
- May 30, 2019
- Last update posted
- Jun 11, 2019
2016 – 2019
United States locations
- U.S. sites
- 2
- U.S. states
- 2
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pacific Institute for Research and Evaluation | Oakland | California | 94612 | — |
| Klein Buendel, Inc. | Golden | Colorado | 80401 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Cannabis trials
Other public records listing Cannabis. Sorted by last update posted; newest first. Not a recommendation.
- NCT07699198: Developing and Strengthening Cannabis Warnings: Warning Message Testing Not yet recruiting
- NCT05401929: Transcranial Magnetic Brain Stimulation to Reduce Cannabis Use in Heavy Cannabis Users Recruiting
- NCT07679581: Cannabis Observations on Brain Waves, Retrieval, and Attention: Experiment 4 Recruiting
- NCT07603518: The Pharmacokinetics of a Hemp-Based Topical Product Not yet recruiting
- NCT07434895: Repeated CBD Administration and Cannabis Outcomes Recruiting
- NCT05514899: Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03073291, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 11, 2019 · Synced Sep 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03073291 live on ClinicalTrials.gov.